Indian Pediatrics

, Volume 50, Issue 12, pp 1137–1143 | Cite as

Challenges in management of irritable bowel syndrome in children

  • Siba Prosad Paul
  • Penny Barnard
  • Charlotte Bigwood
  • David C. A. Candy
Review Article

Abstract

Irritable bowel syndrome (IBS) is a common cause of recurrent abdominal pain (RAP) in children and can be a debilitating experience for both child and family. Organic causes of RAP symptoms such as celiac and inflammatory bowel diseases should be excluded before a diagnosis of IBS is made. Treatment consists of dietary manipulation, drugs, and stress management.

Newer therapies may offer better control of symptoms with minimal side-effects. This article discusses the challenges faced by pediatricians in managing IBS and reviews management in the context of children from the Indian subcontinent.

Keywords

Irritable bowel syndrome Management Recurrent abdominal pain Therapy 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Bremner AR, Sandhu BK. Recurrent abdominal pain in childhood: The functional element. Indian Pediatr. 2009;46:375–379.PubMedGoogle Scholar
  2. 2.
    El-Matary W, Spray C, Sandhu B. Irritable bowel syndrome: the commonest cause of recurrent abdominal pain in children. Eur J Pediatr. 2004;163:584–588.PubMedCrossRefGoogle Scholar
  3. 3.
    Muller-Lissner S, Kock G, Talley NJ, Drossman D, Rueegg P, Dunger-Baldauf C, et al. Subject’s global assessment of relief: an appropriate method to assess the impact of treatment on irritable bowel syndrome-related symptoms in clinical trials. J Clin Epidemiol. 2003:56:310–316.PubMedCrossRefGoogle Scholar
  4. 4.
    Rasquin A, Di Lorenzo C, Forbes D, Guiraldes E, Hyams J, Staiano A, et al. Childhood functional gastrointestinal disorders. Gastroenterology 2006;130: 1527–1537.PubMedCrossRefGoogle Scholar
  5. 5.
    Guandalini S, Magazzu’ G, Chiaro A, La Balestra V, Di Nardo G, Gopalan S, et al. VSL#3 Improves symptoms in children with irritable bowel syndrome: A multicenter, eandomized, placebo-controlled, double-blind, crossover study. J Pediatr Gastroenterol Nutr. 2010;51: 24–30.PubMedCrossRefGoogle Scholar
  6. 6.
    Spiller R, Garsed K. Infection, inflammation, and the irritable bowel syndrome. Dig Liver Dis. 2009;41:844–849.PubMedCrossRefGoogle Scholar
  7. 7.
    Schwille-Kiuntke J, Enck P, Zendler C, Krieg M, Polster AV, Klosterhalfen S, et al. Postinfectious irritable bowel syndrome: follow-up of a patient cohort of confirmed cases of bacterial infection with Salmonella or Campylobacter. Neurogastroenterol Motil. 2011;23:e479–488.PubMedCrossRefGoogle Scholar
  8. 8.
    Thabane M, Simunovic M, Akhtar-Danesh N, Garg AX, Clark WF, Collins SM, et al. An outbreak of acute bacterial gastroenteritis is associated with an increased incidence of irritable bowel syndrome in children. Am J Gastroenterol. 2010;105:933–939.PubMedCrossRefGoogle Scholar
  9. 9.
    Dizdar V, Gilja OH, Hausken T. Increased visceral sensitivity in Giardia-induced postinfectious irritable bowel syndrome and functional dyspepsia. Effect of the 5HT3-antagonist ondansetron. Neurogastroenterol Motil. 2007;19:977–982.Google Scholar
  10. 10.
    Guzyeyeva GV. Giardia lamblia infection in hospitalized children with irritable bowel syndrome and dyspepsia: a prospective study. Faseb J. 2009;980.5 (Abstract).Google Scholar
  11. 11.
    Ghoshal UC, Abraham P, Bhatt C, Choudhuri G, Bhatia SJ, Shenoy KT, et al. Epidemiological and clinical profile of irritable bowel syndrome in India: report of the Indian Society of Gastroenterology Task Force. Indian J Gastroenterol. 2008;27:22–28.PubMedGoogle Scholar
  12. 12.
    Talley NJ. Genetics and Functional bowel disease. J Pediatr Gastroenterol Nutr. 2008; 47:680–682.PubMedCrossRefGoogle Scholar
  13. 13.
    Mulak A, Paradowski L. Migraine and irritable bowel syndrome. Neurol Neurochir Pol. 2005;39:S55–S60.PubMedGoogle Scholar
  14. 14.
    Hyams JS, Burke G, Davis PM, Rzepski B, Andrulonis PA. Abdominal pain and irritable bowel syndrome in adolescents: a community-based study. J Pediatr. 1996;129:220–226.PubMedCrossRefGoogle Scholar
  15. 15.
    Bahar RJ, Collins BS, Steinmetz B, Ament ME. Doubleblind placebo-controlled trial of amitriptyline for the treatment of irritable bowel syndrome in adolescents. J Pediatr. 2008;152:685–689.PubMedCrossRefGoogle Scholar
  16. 16.
    Hoseini-Asl MK, Amra B. Prevalence of irritable bowel syndrome in Shahrekord, Iran. Indian J Gastroenterol. 2003;22:215–216.PubMedGoogle Scholar
  17. 17.
    Candy DCA, Edwards E. The management of chronic constipation. Curr Pediatr. 2003;13: 101–106.CrossRefGoogle Scholar
  18. 18.
    Chiou E, Nurko S. Management of functional abdominal pain and irritable bowel syndrome in children and adolescents. Expert Rev Gastroenterol Hepatol. 2010;4:293–304.PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Benniga MA, Mayer EA. The Power of Placebo in Pediatric Functional Gastrointestinal Disease. Gastroenterology. 2009;137:1207–1210.CrossRefGoogle Scholar
  20. 20.
    Saps M, Youssef N, Miranda A, Nurko S, Hyman P, Cocjin J, et al. Multicenter, randomized placebocontrolled trial of amitriptyline in children with functional gastrointestinal disorders. Gastroenterology. 2009;137:1261–1269.PubMedCentralPubMedCrossRefGoogle Scholar
  21. 21.
    Krogsbøll LT, Hróbjartsson A, Gøtzsche PC. Spontaneous improvement in randomised clinical trials: meta-analysis of three armed trials comparing no treatment, placebo and active intervention. BMC Med Res Methodol. 2009;9:1.PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    Huertas-Ceballos AA, Logan S, Bennett C, Macarthur C. Psychosocial interventions for recurrent abdominal pain(RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD003014.Google Scholar
  23. 23.
    Rutten JM, Reitsma JB, Vlieger AM, Vlieger AM, Benniga MA. Gut-directed hypnotherapy for functional abdominal pain or irritable bowel syndrome in children: a systematic review. Arch Dis Child. 2013; 98:252–257.PubMedCrossRefGoogle Scholar
  24. 24.
    Huertas-Ceballos AA, Logan S, Bennett C, Macarthur C. Pharmacological interventions for recurrent abdominal pain(RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. No.: CD003017.Google Scholar
  25. 25.
    Lebel AA. Pharmacology. J Pediatr Gastroenterol Nutr. 2008;47:703–705.PubMedCrossRefGoogle Scholar
  26. 26.
    Chey WY, Jin HO, Lee MH, Sun SW, Lee KY. Colonic motility abnormality in patients with irritable bowel syndrome exhibiting abdominal pain and diarrhea. Am J Gastroenterol. 2001;96:1499–1506.PubMedCrossRefGoogle Scholar
  27. 27.
    Awad R, Dibildox M, Ortiz F. Irritable bowel syndrome treatment using pinaverium bromide as a calcium channel blocker. A randomized double-blind placebo-controlled trial. Acta Gastroenterol Latinoam. 1995;25:137–144.PubMedGoogle Scholar
  28. 28.
    Karabulut GS, Beer OF, Erginöz E, Kutlu T, Cokuðraη FÇ, Erkan T. The incidence of irritable bowel syndrome in children using the Rome III Criteria and the effect of trimebutine treatment. J Neurogastroenterol Motil. 2013;19:90–93.PubMedCentralPubMedCrossRefGoogle Scholar
  29. 29.
    Teitelbaum JE, Arora R. Long-term efficacy of low-dose tricyclic antidepressants for children with functional gastrointestinal disorders. J Pediatr Gastroenterol Nutr. 2011;53:260–264.PubMedCrossRefGoogle Scholar
  30. 30.
    Snook J, Shepherd HA. Bran supplementation in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther. 1994;8:511–514.PubMedCrossRefGoogle Scholar
  31. 31.
    Paul SP, Barnard P, Edate S, Candy DC. Stool consistency and abdominal pain in irritable bowel syndrome may be improved by partially hydrolysed guar gum. J Pediatr Gastroenterol Nutr. 2011;53:582–583.PubMedGoogle Scholar
  32. 32.
    NICE CG99. Diagnosis and management of idiopathic childhood constipation in primary and secondary care. http://www.nice.org.uk/nicemedia/live/12993/48721/48721.pdf.
  33. 33.
    Cann PA, Read NW, Holdsworth CD, Barends D. Role of loperamide and placebo in management of irritable bowel syndrome (IBS). Dig Dis Sci. 1984;29:239–247.PubMedCrossRefGoogle Scholar
  34. 34.
    Pimentel M, Lembo A, Chey WD, Zakko S, Ringel Y, Yu J, et al. Rifaximin therapy for patients with irritable bowel syndrome without constipation. N Engl J Med. 2011;364:22–32.PubMedCrossRefGoogle Scholar
  35. 35.
    Giorgio V, D’ Andrea V, Coccia P, Filoni S, Rendeli C, Fundarò C. Efficacy of rifaximin for SIBO treatment in IBS children. Pediatr. Res. 2010;68,144.CrossRefGoogle Scholar
  36. 36.
    Huertas-Ceballos AA, Logan S, Bennett C, Macarthur C. Dietary interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database of Systematic Reviews 2009, Issue 1. Art. No.: CD003019.Google Scholar
  37. 37.
    Romano C, Ferrau V, Cavataio F, Iacono G, Spina M, Lionetti E, et al. Lactobacillus reuteri in children with functional abdominal pain (FAP). J Paediatr Child Health. 2010.Jul8. (Epub ahead of print).Google Scholar
  38. 38.
    Chen CC, Walker WA. Clinical applications of probiotics in gastrointestinal disorders in children. Natl Med J India. 2011;24:153–160.PubMedGoogle Scholar
  39. 39.
    Romano C, Comito D, Famini A, Calamarà S, Loddo I. Partially hydrolyzed guar gum in pediatric functional abdominal pain. World J Gastroenterol. 2013;19:235–240.PubMedCrossRefGoogle Scholar
  40. 40.
    Brands MM, Purperhart H, Deckers-Kocken JM. A pilot study of yoga treatment in children with functional abdominal pain and irritable bowel syndrome. Complement Ther Med. 2011;19:109–114.PubMedCrossRefGoogle Scholar

Copyright information

© Indian Academy of Pediatrics 2013

Authors and Affiliations

  • Siba Prosad Paul
    • 1
    • 4
  • Penny Barnard
    • 2
  • Charlotte Bigwood
    • 3
  • David C. A. Candy
    • 2
  1. 1.Bristol Royal Hospital for ChildrenBristolUK
  2. 2.Western Sussex Hospitals NHS Foundation TrustChichesterUK
  3. 3.Evelina Children’s HospitalLondonUK
  4. 4.Department of Pediatric Gastroenterology, Bristol Royal Hospital for ChildrenPaul O’Gorman BuildingBristolUK

Personalised recommendations